Objectives: To determine the prevalence of insulin resistance (IR) in non-diabetic patients with chronic hepatitis C, and to assess the association between IR, laboratory parameters and histological findings. Subjects and methods: Eighty-two patients had their serum analyzed for glucose, lipid profile, C-reactive protein (CRP), ferritin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), HOMA-IR, viral load and HCV genotype. Patients with HOMA-IR levels > 2.5 were considered as carriers of insulin resistance. Results: IR was observed in 27% of patients and was associated with age, waist circumference and body mass index. IR patients were more likely to have more advanced hepatic fibrosis and necroinflammatory activity, higher levels of aminotransferases and liver steatosis than patients without IR. Conclusions: Insulin resistance is often present in patients with chronic hepatitis C, and this parameter is associated with more advanced HCV-related hepatic fibrosis. Arq Bras Endocrinol Metab. 2011;55(6):412-8 Keywords Chronic hepatitis C; liver fibrosis; insulin resistance; HOMA-IR RESUMO Objetivos: Em portadores de hepatite crĂŽnica C nĂŁo diabĂ©ticos, verificar a prevalĂȘncia de resistĂȘncia insulĂnica (RI) e analisar a associação desta com os parĂąmetros laboratoriais e histolĂłgicos. Sujeitos e mĂ©todos: Foram incluĂdos no estudo 82 pacientes, e amostras de sangue foram coletadas para determinação de glicose, perfil lipĂdico, alanina aminotransferase (ALT), aspartato aminotransferase (AST), ferritina, HOMA-IR, carga viral e genĂłtipo do VHC. HOMA--IR superior a 2,5 foi considerado resistĂȘncia insulĂnica. Resultados: RI foi observada em 27% dos pacientes e foi associada a idade, circunferĂȘncia abdominal e Ăndice de massa corpĂłrea. Quando comparado a pacientes sem RI, aqueles com HOMA-IR superior a 2,5 apresentaram graus mais acentuados de fibrose hepĂĄtica e atividade necroinflamatĂłria, maiores nĂveis de aminotransferases e esteatose hepĂĄtica mais frequente. ConclusĂ”es: Ă comum a presença de RI em portadores de hepatite crĂŽnica C e esta se associa com graus mais avançados de fibrose hepĂĄtica induzida pelo vĂrus da hepatite C. Arq Bras Endocrinol Metab. 2011;55(6):412-8 Descritores